Hereditary amyloidosis related to transthyretin V30M: disease progression in treated and untreated patients.

Published in: European journal of neurology (2018)

Both LT and tafamidis therapy modified the natural history of hATTR V30M by reducing neuropathy progression.

Keyphrases